Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 2, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-001936.pdf 0001562180-20-001936.rtf 0001562180-20-001936.xls View HTML
February 18, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-039481.pdf 0001193125-20-039481.rtf 0001193125-20-039481.xls View HTML
February 14, 2020	5	Annual filing director officer or owner of more than ten percent.	0000899243-20-004675.pdf 0000899243-20-004675.rtf View HTML
February 13, 2020	SC 13G/A	An amendment to the SC 13G filing	0001567619-20-003336.pdf 0001567619-20-003336.rtf 0001567619-20-003336.xls View HTML
February 13, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-20-020227.pdf 0001104659-20-020227.rtf 0001104659-20-020227.xls View HTML
February 6, 2020	CT ORDER	CT ORDER	9999999997-20-000529.pdf 9999999997-20-000529.rtf View HTML
February 5, 2020	SC 13G/A	An amendment to the SC 13G filing	0000834237-20-004641.pdf 0000834237-20-004641.rtf View HTML
January 24, 2020	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-20-014184.pdf 0001193125-20-014184.rtf 0001193125-20-014184.xls View HTML
November 22, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-005642.pdf 0001562180-19-005642.rtf View HTML
November 22, 2019	4	Statement of changes in beneficial ownership of securities	0001562180-19-005641.pdf 0001562180-19-005641.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax